SCHEMBL131675

SCHEMBL131675

C=C(CCC(O)COc1ccccc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 1/20 0.46
PTGER1 P34995 1/20 0.46
PTGFR P43088 1/20 0.46
PTGER3 P43115 1/20 0.46
PTGDR Q13258 1/20 0.46
LMNA P02545 2/20 0.46
CYP2D6 P10635 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
ADRB3 P13945 1/20 0.45
MEN1 O00255 1/20 0.44
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
MAPT P10636 2/20 0.43
TSHR P16473 1/20 0.43
HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL8964171 0.94 MAPT (0.45) TBXA2RPTGER1PTGFRPTGER3PTGDR
SCHEMBL15239093 0.88 PRMT5 (0.46)
SCHEMBL867192 0.86 RAB9A (0.54) MEN1KMT2AKDM4EMAPT
SCHEMBL378569 0.85 ADRB2 (0.52) L3MBTL1ADRB2ADRB1ADRB3MEN1
SCHEMBL2204843 0.85 TBXA2R (0.39) TBXA2RPTGER1PTGFRPTGER3PTGDR
SCHEMBL183191 0.84 LMNA (0.49) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL865586 0.80 ADRB2 (0.51) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL5679630 0.80 PPARG (0.36) TBXA2RPTGER1PTGFRPTGER3PTGDR
SCHEMBL866457 0.79 CYP1A2 (0.58) LMNACYP2D6ADRB2ADRB1ADRB3
Methacrylic Acid SCHEMBL28914843 0.79 LMNA (0.57) LMNACYP2D6L3MBTL1ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1066 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3690993-B1 COMPOSITIONS FOR FORMING A POROUS INSULATING LAYER, ELECTRODE FOR NON-AQUEOUS ELECTROLYTE RECHARGEABLE BATTERY, RECHARGEABLE BATTERY INCLUDING THE ELECTRODE AND METHOD OF MANUFACTURING THE ELECTRODE SAMSUNG SDI CO LTD (KR) 2023-10-04 EP claimed
US-20220249331-A1 METHOD OF MANUFACTURING MONOMER COMPOSITION, RAW MATERIAL COMPOSITION, MONOMER COMPOSITION, CURABLE COMPOSITION, AND MOLDED BODY MITSUI CHEMICALS, INC. (JP) 2022-08-11 US claimed
EP-3988592-A1 MONOMER COMPOSITION PRODUCTION METHOD, MATERIAL COMPOSITION, MONOMER COMPOSITION, CURABLE COMPOSITION, AND MOLDED ARTICLE Mitsui Chemicals, Inc. (JP) 2022-04-27 EP claimed
EP-3470477-B1 RADIATION-CURABLE INK JET INK COMPOSITION AND INK JET RECORDING METHOD SEIKO EPSON CORP (JP) 2021-04-21 EP claimed
EP-2540515-B1 INK COMPOSITION FOR CLEAR LAYER FORMATION, COATING METHOD FOR SAME, AND PRINTED ARTICLE USING SAME MAXELL HOLDINGS LTD (JP) 2020-06-17 EP claimed
EP-3494186-B1 INKJET INK COMPOSITION HEWLETT PACKARD DEVELOPMENT CO (US) 2020-04-15 EP claimed
US-10294380-B2 Three-dimensional shaped article manufacturing method, three-dimensional shaped article manufacturing apparatus, ink set, and three-dimensional shaped article SEIKO EPSON CORPORATION (JP) 2019-05-21 US claimed
US-10286578-B2 Three-dimensional shaped article manufacturing apparatus SEIKO EPSON CORPORATION (JP) 2019-05-14 US claimed
US-9718996-B2 Composition and method for temporarily fixing member using same DENKA COMPANY LIMITED (JP) 2017-08-01 US claimed
US-9579852-B2 Method for manufacturing three-dimensional shaped object SEIKO EPSON CORPORATION (JP) 2017-02-28 US claimed
US-20040186241-A1 Photochromic ocular devices TRANSITIONS OPTICAL, INC. 2004-09-23 US claimed
WO-2004024814-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO., LTD. (KR) 2004-03-25 WO claimed
WO-2003072625-A1 PHOTOCURABLE RESIN COMPOSITION FOR OPTICAL WAVEGUIDE AND OPTICAL WAVEGUIDE MADE OF THE SAME LUVANTIX CO., LTD. (KR) 2003-09-04 WO claimed
EP-0759448-B1 Ionizing radiation-curable resin composition for optical article, optical article, and surface light source DAINIPPON PRINTING CO LTD (JP) 2002-01-30 EP claimed
EP-0465672-B1 PHOTOCURABLE RESIN COMPOSITION AND PROCESS FOR PRODUCING PHOTOCURABLE RESIN NIPPON PETROCHEMICALS CO LTD (JP) 1996-11-20 EP claimed
EP-0562861-B1 Optical materials with a high refractive index and method for producing the same MITSUBISHI CHEM CORP (JP) 1996-05-29 EP claimed
EP-0465670-B1 PHOTOCURABLE RESIN COMPOSITION NIPPON PETROCHEMICALS CO LTD (JP) 1996-04-10 EP claimed
EP-0465669-B1 PHOTOCURABLE RESIN COMPOSITION NIPPON PETROCHEMICALS CO LTD (JP) 1996-04-03 EP claimed
EP-0370753-B1 Modified polyolefin particles and process for preparation thereof MITSUI PETROCHEMICAL IND (JP) 1995-01-18 EP claimed
US-4777191-A TETRAPEROXY ESTERS OF BENZOPHENONE NIPPON OIL & FATS CO., LTD. (JP) 1988-10-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220249331-A1 METHOD OF MANUFACTURING MONOMER COMPOSITION, RAW MATERIAL COMPOSITION, MONOMER COMPOSITION, CURABLE COMPOSITION, AND MOLDED BODY TST, CPT1A, TMT1A TBXA2R 4881/4885PTGER1 3702/4885PTGFR 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.